Document Detail

Randomized placebo-controlled study on the characteristics and duration of action of surfactant treatment in premature lambs.
MedLine Citation:
PMID:  8148579     Owner:  NLM     Status:  MEDLINE    
In a placebo-controlled study, the characteristics and duration of action of a commercially available bovine lung surfactant factor (LSF; 50 mg/kg body weight) were investigated in premature lambs at 124-127 days gestational age. Exact mating of ewes was controlled by progesterone hormone analysis. To minimize unwanted effects of narcotics through transplacental transfer to the fetus, spinal anaesthesia of the ewes was performed. The physiological status 'in utero' was demonstrated by arterial blood gas analysis (partial arterial oxygen pressure (PaO2), partial arterial carbon dioxide pressure (PaCO2) and arterial blood pH) of the fetus before umbilical cord ligature. The values for blood gases, blood pressure and lung mechanics measured after onset of ventilation and before LSF treatment were indicative of fetal maturity. Immediately after LSF treatment, PaO2 increased significantly, then decreased for about 2 h and finally stabilized on a plateau until the end of the experiment. In contrast, arterial blood pH and PaCO2 values normalized more slowly and remained normal for a longer period in the LSF group, whereas both parameters did not normalize in the placebo group. Total dynamic lung compliance also showed a slow improvement and remained on a higher level for a longer period than PaO2. Using a low respiratory rate it was possible to ventilate at lower peak inspiratory pressures and this resulted in higher compliance values. In conclusion, the presented data suggest that artificial ventilation greatly influences lung mechanics. Due to a relatively short substance effect concerning PaO2 we assume that higher or repeated doses of LSF may be necessary to produce sustained improvements in clinical trials.
D Häfner; G Hanauer; U Kilian; R Beume; G Dillmann
Related Documents :
6846949 - Fluid balance in the air filled alveolar space.
6687549 - Role of lung surfactant in cerebral decompression sickness.
989609 - Effect of ventilation on movement of surfactant in airways.
24831499 - Mechanical influences in progressive intervertebral disc degeneration.
10027019 - Combined effects of high-frequency ventilation and surfactant treatment in experimental...
16338299 - Liver position in fetal congenital diaphragmatic hernia retains a prognostic value in t...
20843769 - The assessment of rat ureteral pressure generation in vitro: regional heterogeneity and...
12791409 - Characterization of arterial stenosis and elasticity by analysis of high-frequency pres...
19172089 - Bicycle saddle pressure: effects of trunk position and saddle design on healthy subjects.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  Pulmonary pharmacology     Volume:  6     ISSN:  0952-0600     ISO Abbreviation:  Pulm Pharmacol     Publication Date:  1993 Dec 
Date Detail:
Created Date:  1994-05-10     Completed Date:  1994-05-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9007551     Medline TA:  Pulm Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  255-62     Citation Subset:  IM    
Bky Gulden Lomberg Chemische Fabrik GmbH, Department of Respiratory Pharmacology, Konstanz, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Carbon Dioxide / blood
Disease Models, Animal
Feasibility Studies
Fetal Blood / drug effects,  physiology
Lipids / therapeutic use*
Oxygen / blood
Partial Pressure
Pulmonary Surfactants / therapeutic use*
Random Allocation
Respiration Disorders / drug therapy*
Time Factors
Reg. No./Substance:
0/Lipids; 0/Phospholipids; 0/Placebos; 0/Pulmonary Surfactants; 0/SF-RI 1, bovine surfactant preparation; 124-38-9/Carbon Dioxide; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Inhibitory effect of a thromboxane A2 synthetase inhibitor OKY-046 on bronchial hyperresponsiveness ...
Next Document:  The integrity of the epithelium is a major determinant of the responsiveness of the dog bronchial se...